Davidson Kempner Capital Management LP filed a Form 8.3 related to Tate & Lyle plc.

An article discusses Tate & Lyle's position as a notable entity in stock market trivia.

Ingredion has reached an agreement to purchase Tate & Lyle in a deal valued at $3.6 billion, expanding its market presence.

Tate & Lyle, a company reportedly targeted for takeover by Ingredion, has announced a fall in its profits.

Ingredion has made a $3.7 billion offer to acquire its ingredients rival, Tate & Lyle, in a significant move within the food ingredients industry.

Ingredion projects its 2026 adjusted EPS to be between $10.30 and $10.90, while continuing to advance its deal with Tate & Lyle, aiming for $130 million in run-rate synergies by 2030.

Tate & Lyle, a British food and beverage ingredient company, has been sold to a US rival, representing another significant company loss for the London market.

Ingredion is reportedly close to finalizing a $3.6 billion deal to acquire Tate & Lyle, marking another significant loss for the London market.

British food ingredients company Tate & Lyle is reportedly in discussions with a US rival regarding a possible £2.7 billion takeover bid.

Tate & Lyle announced highlights from its third-quarter earnings call, providing an overview of the company's financial results.

Jim Cramer provided his investment insights on a range of companies, including Ford's battery business, banks like JPMorgan, Stryker, Vistra, Clover Health, Fair Isaac, Archer-Daniels-Midland, Tyson Foods, and Ingredion's potential after the Tate & Lyle deal.

Tate & Lyle announced non-GAAP EPS of 40.40p and adjusted revenue of £2.01 billion, while also providing its financial outlook for fiscal year 2027.